Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance

Human Pathology

Volumn 44, Issue 9, 2013, Pages 1838-1848

  Lien, Huang Chun ^a   Wang, Chung Chieh ^a   Lin, Ching Hung ^a   Lu, Yen Shen ^a   Huang, Chiun Sheng ^a   Hsiao, Li Ping ^a   Yao, Yu Tung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Breast; Carcinoma; Epithelial mesenchymal transition; Metaplastic carcinoma; UCHL1

Indexed keywords

TRANSCRIPTION FACTOR SNAIL; UBIQUITIN CARBOXY TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST CARCINOMA; CELL INVASION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PHENOTYPE; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER;

BREAST; CARCINOMA; EPITHELIAL MESENCHYMAL TRANSITION; METAPLASTIC CARCINOMA; UCHL1;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOSARCOMA; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MCF-7 CELLS; METAPLASIA; NEOPLASM INVASIVENESS; SURVIVAL RATE; TAIWAN; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN THIOLESTERASE;

EID: 84883445547     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.02.006     Document Type: Article

References (33)

1. A. Bheda, J. Shackelford, and J.S. Pagano Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes PLoS One 4 2009 e6764
2. K.D. Wilkinson Regulation of ubiquitin-dependent processes by deubiquitinating enzymes FASEB J 11 1997 1245 1256
3. D. Komander, M.J. Clague, and S. Urbe Breaking the chains: structure and function of the deubiquitinases Nat Rev Mol Cell Biol 10 2009 550 563
4. F.E. Reyes-Turcu, K.H. Ventii, and K.D. Wilkinson Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes Annu Rev Biochem 78 2009 363 397
5. H. Sasaki, H. Yukiue, and S. Moriyama Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer Jpn J Clin Oncol 31 2001 532 535
6. T. Yamazaki, K. Hibi, and T. Takase PGP9.5 as a marker for invasive colorectal cancer Clin Cancer Res 8 2002 192 195
7. E. Tezel, K. Hibi, T. Nagasaka, and A. Nakao PGP9.5 as a prognostic factor in pancreatic cancer Clin Cancer Res 6 2000 4764 4767
8. T. Takase, K. Hibi, and T. Yamazaki PGP9.5 overexpression in esophageal squamous cell carcinoma Hepatogastroenterology 50 2003 1278 1280
9. S. Hussain, O. Foreman, and S.L. Perkins The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling Leukemia 24 2010 1641 1655
10. H.C. Lien, C.C. Wang, C.S. Huang, Y.W. Yang, W.H. Kuo, and Y.T. Yao Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors Virchows Arch 462 2013 155 161
11. F. Sato, and S.J. Meltzer CpG island hypermethylation in progression of esophageal and gastric cancer Cancer 106 2006 483 493
12. J. Yu, Q. Tao, and K.F. Cheung Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors Hepatology 48 2008 508 518
13. D.L. Mandelker, K. Yamashita, and Y. Tokumaru PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma Cancer Res 65 2005 4963 4968
14. I. Kagara, H. Enokida, and K. Kawakami CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma J Urol 180 2008 343 351
15. R. Ummanni, E. Jost, and M. Braig Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation Mol Cancer 10 2011 129
16. T. Kumagai, T. Akagi, and J.C. Desmond Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells Int J Cancer 124 2009 827 833
17. Y. Tokumaru, K. Yamashita, and M.S. Kim The role of PGP9.5 as a tumor suppressor gene in human cancer Int J Cancer 123 2008 753 759
18. Y. Miyoshi, S. Nakayama, and Y. Torikoshi High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer Cancer Sci 97 2006 523 529
19. T. Xiang, L. Li, and X. Yin The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer PLoS One 7 2012 e29783
20. Y. Akishima-Fukasawa, Y. Ino, and Y. Nakanishi Significance of PGP9.5 expression in cancer-associated fibroblasts for prognosis of colorectal carcinoma Am J Clin Pathol 134 2010 71 79
21. H.C. Lien, Y.S. Lu, C.T. Shun, Y.T. Yao, W.C. Chang, and A.L. Cheng Differential expression of glucocorticoid receptor in carcinomas of the human digestive system Histopathology 52 2008 314 324
22. H.C. Lien, Y.H. Hsiao, and Y.S. Lin Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition Oncogene 26 2007 7859 7871
23. B.P. Zhou, J. Deng, and W. Xia Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition Nat Cell Biol 6 2004 931 940
24. H.J. Kim, Y.M. Kim, S. Lim, Y.K. Nam, J. Jeong, and K.J. Lee Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis Oncogene 28 2009 117 127
25. M.J. Jang, S.H. Baek, and J.H. Kim UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction Cancer Lett 302 2011 128 135
26. D. Sarrio, S.M. Rodriguez-Pinilla, D. Hardisson, A. Cano, G. Moreno-Bueno, and J. Palacios Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype Cancer Res 68 2008 989 997
27. B. Weigelt, F.C. Geyer, and J.S. Reis-Filho Histological types of breast cancer: how special are they? Mol Oncol 4 2010 192 208
28. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 2002 442 454
29. H. Acloque, M.S. Adams, K. Fishwick, M. Bronner-Fraser, and M.A. Nieto Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease J Clin Invest 119 2009 1438 1449
30. T. Brabletz, F. Hlubek, and S. Spaderna Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin Cells Tissues Organs 179 2005 56 65
31. H.J. Yoo, B.R. Yun, and J.H. Kwon Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells Exp Mol Med 41 2009 102 115
32. B. Weigelt, H.M. Horlings, and B. Kreike Refinement of breast cancer classification by molecular characterization of histological special types J Pathol 216 2008 141 150
33. B.T. Hennessy, A.M. Gonzalez-Angulo, and K. Stemke-Hale Characterization of a naturally occurring breast cancer subset enriched in epithelial-to- mesenchymal transition and stem cell characteristics Cancer Res 69 2009 4116 4124